Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Episurf Medical ABLTS:0QUT +2.67% EV-to-OCF is 267.91 as of Sep. 08, 2026. The stock has 5 warning signs investors should review. Among 850 Medical Devices & Instruments companies, Episurf Medical AB ranks worse than 98.94% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Episurf Medical AB's Enterprise Value is kr1,393.12 Mil.
Episurf Medical AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was kr5.20 Mil. Therefore, Episurf Medical AB's EV-to-OCF for today is 267.91.
The historical rank and industry rank for Episurf Medical AB's EV-to-OCF or its related term are showing as below:
LTS:0QUT'
s EV-to-OCF Range Over the Past 10 Years
Min: -27.49 Med: -1.97 Max: 265.31
Current: 265.31
During the past 13 years, the highest EV-to-OCF of Episurf Medical AB was 265.31. The lowest was -27.49. And the median was -1.97.
LTS:0QUT's EV-to-OCF is ranked worse than 98.94% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 8.045
vs LTS:0QUT: 265.31
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Episurf Medical AB (LTS:0QUT) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Episurf Medical AB's PE Ratio (TTM) for today is calculated as:
Episurf Medical AB's share price for today is kr0.077.
Episurf Medical AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.070.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Episurf Medical AB EV-to-OCF Related Terms
Episurf Medical AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Episurf Medical AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Episurf Medical AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Episurf Medical AB EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Episurf Medical AB's EV-to-OCF falls into.
Episurf Medical AB's current Enterprise Value is kr1,393.12 Mil.
Episurf Medical AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr5.20 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Episurf Medical AB (LTS:0QUT) has a EV-to-OCF of 267.91 as of Sep. 08, 2026. According to the industry distribution chart, Episurf Medical AB ranks #841 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 98.9%.
Is Episurf Medical AB's EV-to-OCF too high?
Episurf Medical AB's current EV-to-OCF is 267.91. The Medical Devices & Instruments industry median EV-to-OCF is 8.05. Episurf Medical AB's value of 267.91 is 3230.1% above this industry median. Based on the distribution chart, Episurf Medical AB ranks #841 out of 850 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Episurf Medical AB's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Episurf Medical AB ranks #841 out of 850 companies for EV-to-OCF. This places Episurf Medical AB in the lower half of its industry. The industry median EV-to-OCF is 8.05. Episurf Medical AB's value of 267.91 is 3230.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 8.05, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Episurf Medical AB's current EV-to-OCF of 267.91 is 3230.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Episurf Medical AB's current EV-to-OCF is 267.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Episurf Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Episurf Medical AB (LTS:0QUT) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.08 — trading 54% above its estimated fair value. The current EV-to-OCF is 267.91 and 3230.1% above the Medical Devices & Instruments industry median of 8.05. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Episurf Medical AB (LTS:0QUT), the current EV-to-OCF is 267.91 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint. The company is forming a new strategic business segment through the acquisition of real estate assets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QUT has been successfully added to your 
